Alpelisib - where to buy Piqray

Alpelisib (Alpelisib)-PiqrayThe original drug is not on the market in China, so it cannot be included in the medical insurance. Patients in need cannot yet purchase this drug from China. According toNCCN Breast Cancer Guidelines, Apelvis is the preferred treatment option for PIK3CA-mutated breast cancer. For recurrent or stage IV breast cancer in patients with HR-positive, HER2-negative, and postmenopausal patients with PIK3CA-mutated tumors, apelviscombination with fulvestrant is an NCCN Category 1 recommendation. There are European and Indian versions of the original Apellis drug sold overseas. The ingredients of the drugs are basically the same. There is currently no generic version of Apellis on the market. For specific prices and drug information of Apellis, please consult a medical consultant.